La Vigne aux Pères (Port-sur-Saône), Pré Bouche (Seveux), Les Jourdaines (Jonvelle), Saint-Martin (Faucogney-et-la-Mer) (Haute-Saône). « Le Portois du ive au xiie s., évolution des... von Saggese, Adrien, Chevassu, Valentin, Chenal, Thomas

Volltext

Jonvelle, Port-sur-Saône, Seveux (Haute-Saône). Aux Jourdaines, La Vigne aux Pères, Pré Bouché von Saggese, Adrien, Chevassu, Valentin, Chenal, Thomas

Volltext

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC von Ramalingam, Suresh S, Vansteenkiste, Johan, Planchard, David, Cho, Byoung Chul, Gray, Jhanelle E, Ohe, Yuichiro, Zhou, Caicun, Reungwetwattana, Thanyanan, Cheng, Ying, Chewaskulyong, Busyamas, Shah, Riyaz, Cobo, Manuel, Lee, Ki Hyeong, Cheema, Parneet, Tiseo, Marcello, John, Thomas, Lin, Meng-Chih, Imamura, Fumio, Kurata, Takayasu, Todd, Alexander, Hodge, Rachel, Saggese, Matilde, Rukazenkov, Yuri, Soria, Jean-Charles

Volltext

Granulomatous Encephalomyelitis and Intestinal Ganglionitis in a Spectacled Amazon Parrot ( Amazona albifrons) Infected with Mycobacterium genavense von Gomez, G., Saggese, M.D., Weeks, B.R., Hoppes, S.M., Porter, B.F.

Volltext

WNT5A regulates adipose tissue angiogenesis via antiangiogenic VEGF-A165b in obese humans von Karki, Shakun, Ngo, Doan T M, Farb, Melissa G, Park, Song Young, Saggese, Samantha M, Hamburg, Naomi M, Carmine, Brian, Hess, Donald T, Walsh, Kenneth, Gokce, Noyan

Volltext

Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor κB ligand (RANKL) in human breast tumours von Van Poznak, C, Cross, S S, Saggese, M, Hudis, C, Panageas, K S, Norton, L, Coleman, R E, Holen, I

Volltext

Humoral response to Mycobacterium avium subsp. avium in naturally infected ring-neck doves ( Streptopelia risoria) von Gray, P.L., Saggese, M.D., Phalen, D.N., Tizard, I.

Volltext

ncx1, ncx2, and ncx3 Gene Product Expression and Function in Neuronal Anoxia and Brain Ischemia von ANNUNZIATO, L., PIGNATARO, G., BOSCIA, F., SIRABELLA, R., FORMISANO, L., SAGGESE, M., CUOMO, O., GALA, R., SECONDO, A., VIGGIANO, D., MOLINARO, P., VALSECCHI, V., TORTIGLIONE, A., ADORNETTO, A., SCORZIELLO, A., CATALDI, M., DI RENZO, G. F.

Volltext

Chronic Milk-Alkali Syndrome: PUB157 von Saggese, Samantha M., Alotaibi, Manal

Volltext

WNT5A-JNK regulation of vascular insulin resistance in human obesity von Farb, Melissa G, Karki, Shakun, Park, Song-Young, Saggese, Samantha M, Carmine, Brian, Hess, Donald T, Apovian, Caroline, Fetterman, Jessica L, Bretón-Romero, Rosa, Hamburg, Naomi M, Fuster, José J, Zuriaga, María A, Walsh, Kenneth, Gokce, Noyan

Volltext

WNT5A regulates adipose tissue angiogenesis via antiangiogenic VEGF-A 165 b in obese humans von Karki, Shakun, Ngo, Doan T M, Farb, Melissa G, Park, Song Young, Saggese, Samantha M, Hamburg, Naomi M, Carmine, Brian, Hess, Donald T, Walsh, Kenneth, Gokce, Noyan

Volltext

Approche diachronique des sites de hauteur: des âges des Métaux, de l’Antiquité tardive et du haut Moyen Âge

Volltext

185TiP A phase Ib dose-escalation study evaluating trastuzumab deruxtecan (T-DXd) and durvalumab in combination with chemotherapy as first-line treatment in patients with advanced... von Planchard, D., Yang, J.C-H., Brahmer, J.R., Ragone, A., Chen, J., Liu, F., Saggese, M.

Volltext

P1.01-88 Osimertinib Maintenance After Definitive Chemoradiation in Patients with Unresectable EGFRm-Positive Stage III NSCLC (LAURA) von Shun, L., Nash, T., Saggese, M., Mann, H., Ramalingam, S.

Volltext

Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage von De Nardo, Pasquale, Gentilotti, Elisa, Mazzaferri, Fulvia, Cremonini, Eleonora, Hansen, Paul, Goossens, Herman, Tacconelli, Evelina, Durante Mangoni, E., Florio, L.L., Zampino, R., Mele, F., Gentile, I., Pinchera, B., Coppola, N., Pisaturo, M., Luzzati, R., Petrosillo, N., Nicastri, E., Corpolongo, A., Cataldo, M.A., D’Abramo, A., Maffongelli, G., Scorzolini, L., Palazzolo, C., Boumis, E., Pan, A., D’Arminio Monforte, A., Bai, F., Antinori, S., De Rosa, F.G., Corcione, S., Lupia, T., Pinna, S.M., Scabini, S., Canta, F., Belloro, S., Bisoffi, Z., Angheben, A., Gobbi, F., Turcato, E., Ronzoni, N., Moro, L., Calabria, S., Rodari, P., Bertoli, G., Marasca, G., Puoti, M., Gori, A., Bandera, A., Mangioni, D., Rizzi, M., Castelli, F., Montineri, A., Coco, C.A., Maresca, M., Frasca, M., Aquilini, D., Vincenzi, M., Lambertenghi, L., De Rui, M.E., Razzaboni, E., Cattaneo, P., Visentin, A., Erbogasto, A., Dalla Vecchia, I., Coledan, I., Vecchi, M., Be, G., Motta, L., Zaffagnini, A., Auerbach, N., Del Bravo, P., Azzini, A.M., Righi, E., Carrara, E., Savoldi, A., Sibani, M., Lattuada, E., Carolo, G., Cordioli, M., Soldani, F., Pezzani, M.D., Avallone, S., Bruno, R., Ricciardi, A., Saggese, M.P., Malerba, G.

Volltext

58P Validation of the Achilles VELOS process 2 manufacturing platform for the treatment of solid cancer: GMP scale runs generate a significant dose boost of highly potent clonal ne... von Samuel, E.R., Rologi, E., Fraser, H., Sassi, M., Pruchniak, M., Kotsiou, E., Robinson, J., Benzekhroufa, K., Goodsell, L., Carolan, C., Saggese, M., Grant, M., Samways, B., Kotecha, P., Schmitt, A., Lawrence, D., Forster, M., Turajlic, S., Lowdell, M., Quezada, S.

Volltext

374TiP LAURA: Osimertinib maintenance following definitive chemoradiation therapy (CRT) in patients (pts) with unresectable stage III epidermal growth factor receptor mutation posi... von Lu, S., Casarini, I., Kato, T., Dols, M. Cobo, Özgüroğlu, M., Zeng, L., van der Gronde, T., Saggese, M., Ramalingam, S.

Volltext

1295P Osimertinib vs comparator EGFR-TKI as first-line treatment for EGFR mutated (EGFRm) advanced NSCLC: FLAURA China study overall survival (OS) von Cheng, Y., He, Y., Li, W., Zhang, H-L., Zhou, Q., Wang, B., Liu, C., Walding, A., Saggese, M., Huang, X., Liu, Y., Su, R., Ramalingam, S.S.

Volltext

A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer von Macpherson, IR, Spiliopoulou, P, Rafii, S, Saggese, M, Baird, RD, Garcia-Corbacho, J, Italiano, A, Bonneterre, J, Campone, M, Cresti, N, Posner, J, Takeda, Y, Arimura, A, Spicer, J

Volltext

MA15.03 PD-L1 Expression in Untreated EGFRm Advanced NSCLC and Response to Osimertinib and SoC EGFR-TKIs in the FLAURA Trial von Brown, H., Vansteenkiste, J., Nakagawa, K., Cobo Dols, M., John, T., Barker, C., Kohlmann, A., Todd, A., Saggese, M., Chmielecki, J., Markovets, A., Ramalingam, S.

Volltext